Human Insulin Market by Product for Type 1 Diabetes, Type 2 Diabetes Application and Forecast, 2015 – 2021

Human Insulin Market by Product for Type 1 Diabetes, Type 2 Diabetes Application and Forecast, 2015 – 2021

Comments Off on Human Insulin Market by Product for Type 1 Diabetes, Type 2 Diabetes Application and Forecast, 2015 – 2021

According to the report, the global Human Insulin Market accounted for USD 27.00 billion in 2015 and is expected to reach USD 43.6 billion by 2021, growing at a CAGR of around 8.3% between 2016 and 2021. The global human insulin market is expected to witness significant growth during the forecast period. This growth is attributed due to increasing the risk of diabetes, rising market demand for human insulin analogs, technological advancements in the field of human insulin delivery devices, and favorable medical reimbursements.




According to the report, the global Human Insulin Market accounted for USD 27.00 billion in 2015 and is expected to reach USD 43.6 billion by 2021, growing at a CAGR of around 8.3% between 2016 and 2021.

Diabetes is described as a group of metabolic diseases in which the person has high blood glucose level than normal, either because insulin production is inadequate, or because the body’s cells do not respond properly to insulin. Diabetes is a lifelong condition that is characterized by a raised blood glucose level. Diabetes is characterized into two types of diabetes: Insulin dependent diabetes mellitus (type 1) and Non-insulin dependent diabetes mellitus (type 2). Signs of diabetes include an increased sense of thirst, frequent urination, fatigue, weight and muscle loss, delayed wound healing and blurred vision. Human insulin therapy is utilized for the treatment of both type1 and type 2 diabetes mellitus.

The global rise in human insulin market is mainly due to the increase in diabetic disorder patient across the globe. Moreover, the factors those are responsible for increasing numbers of the diabetic population globally include sedentary lifestyles, obesity, the rise in geriatric populations and poor healthcare services. Furthermore, advanced technology like pen device, safety pen needles for efficient delivery of insulin is fueling the growth of the global human insulin market. However, production cost, manufacturing complexities and critical regulatory requirements for the approval of biotechnology derived products are factors which are expected to restraint the growth of the global human insulin market. Nonetheless, pipeline insulin products and untapped market of Asia Pacific and Africa are major opportunities for upcoming manufacturers of global human insulin markets.

Global Human Insulin Market

Based on products, the global human insulin market is segmented into two types: drugs and drug delivery devices. Drugs segment of human insulin market was contributing maximum market shares in 2015 followed by drug delivery devices. This segment is propelled by factors which include increasing in insulin dependent diabetic population, low cost, growing R&D for drug discovery, rising proportion of aging population in developed countries. In addition, increasing market accessibility of generic human insulin and rising government initiatives to support the development and commercialization of effective biosimilars are expected to fuel the growth of human insulin market over the forecast period

Based on drug type, the global human insulin market is segmented into two types: Biosimilars and Human Insulin Biologics. In terms of revenue, biosimilars were the leading segment of human insulin market in 2015 followed by human Insulin biologics. Meanwhile, biosimilar will rise approximately at a steady CAGR of 7.34% during the forecast period.

Based on application, the global human insulin market is segmented into two types: type 1 diabetes and type 2 diabetes. Type 1 diabetes mellitus was the dominating segment in terms of revenue generated in 2015 followed by type 2 diabetes mellitus. Type 1 Diabetes Mellitus is an autoimmune disorder characterized by a lack of insulin formation in the body. About 100,000 new cases are diagnosed annually in North America. Human insulin serves as only medication for treating type 1 diabetes mellitus.

Key market players of human insulin market include Eli Lilly, GlaxoSmithCline, Biocon, Sanofi Aventis, Julphar, Novo Nordisk, SemBioSys, and Wockhardt.

  • Chapter 1. Introduction
    • 1.1. Report Description And Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Human Insulin Market, 2015 – 2021 (USD Billion)
    • 2.2. Global Human Insulin Market: Snapshot
  • Chapter 3. Human Insulin – Market Dynamics
    • 3.1. Introduction
    • 3.2. Value Chain Analysis
    • 3.3. Market Drivers
      • 3.3.1. Global Human Insulin Market Drivers: Impact Analysis
      • 3.3.2. Rise in Diabetic Patient Population.
      • 3.3.3. Increasing Population Exposure to Key Risk Factors Leading to Diabetes.
    • 3.4. Market Restraints
      • 3.4.1. Global Human Insulin Market Restraints: Impact Analysis
      • 3.4.2. Stringent Regulatory Requirements for Product Approval.
    • 3.5. Opportunities
      • 3.5.1. Emerging Markets
    • 3.6. Porter’s Five Forces Analysis
      • 3.6.1. Bargaining Power Of Suppliers
      • 3.6.2. Bargaining Power Of Buyers
      • 3.6.3. Threat From New Entrants
      • 3.6.4. Threat From New Substitutes
      • 3.6.5. Degree Of Competition
    • 3.7. Market Attractiveness Analysis
      • 3.7.1. Market Attractiveness Analysis, By Type Segment
      • 3.7.2. Market Attractiveness Analysis, By Application Segment
      • 3.7.3. Market Attractiveness Analysis, By Regional Segment
  • Chapter 4. Global Human Insulin Market – Competitive Landscape
    • 4.1. Company Market Share, 2015 (Subject To Data Availability)
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Type Launch
      • 4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures
      • 4.2.4. Research And Development, Product And Regional Expansion
    • 4.3. Product Portfolio
    • 4.4. Patent Analysis (2011-2016)
      • 4.4.1. Patent Trend
      • 4.4.2. Patent Share By Company
      • 4.4.3. By Region
  • Chapter 5. Global Human Insulin Market – Product Segment Analysis
    • 5.1. Global Human Insulin Market: Product Segment Overview
      • 5.1.1. Global Human Insulin Market Revenue Share, By Product Segment, 2015 And 2021
    • 5.2. Drug
      • 5.2.1. Global Human Insulin Market For Drug , 2015 – 2021 (USD Billion)
      • 5.2.2. Insulin Analogs and Biosimilars
        • 5.2.2.1. Global Human Insulin Market For Insulin Analogs and Biosimilars, 2015 – 2021 (USD Billion)
      • 5.2.3. Human Insulin Biologics
        • 5.2.3.1. Global Human Insulin Market For Human Insulin Biologics, 2015 – 2021 (USD Billion)
    • 5.3. Drug Delivery Devices
      • 5.3.1. Global Human Insulin Market For Drug Delivery Devices, 2015 – 2021 (USD Billion)
      • 5.3.2. Pens
        • 5.3.2.1. Global Human Insulin Market For Pens, 2015 – 2021 (USD Billion)
      • 5.3.3. Pen Needles
        • 5.3.3.1. Global Human Insulin Market For Pen Needles, 2015 – 2021 (USD Billion)
      • 5.3.4. Syringes
        • 5.3.4.1. Global Human Insulin Market For Syringes, 2015 – 2021 (USD Billion)
  • Chapter 6. Global Human Insulin Market – Application Segment Analysis
    • 6.1. Global Human Insulin Market: Application Segment Overview
      • 6.1.1. Global Human Insulin Market Revenue Share, By Application Segment, 2015 And 2021
    • 6.2. Insulin Dependent Diabetes Mellitus (Type 1)
      • 6.2.1. Global Human Insulin Market For Insulin Dependent Diabetes Mellitus, 2015 – 2021 (USD Billion)
    • 6.3. Non-Insulin Dependent Diabetes Mellitus (Type 2)
      • 6.3.1. Global Human Insulin Market For Non-Insulin Dependent Diabetes Mellitus, 2015 – 2021 (USD Billion)
  • Chapter 7. Global Human Insulin Market – Regional Segment Analysis
    • 7.1. Global Human Insulin Market: Regional Overview
      • 7.1.1. Global Human Insulin Market Revenue Share, By Region, 2015 And 2021
      • 7.1.2. Global Human Insulin Market Revenue Share, By Application, 2015 And 2021
    • 7.2. North America
      • 7.2.1. North America Human Insulin Market Revenue, By Product, 2015 – 2021 , (USD Billion)
      • 7.2.2. North America Human Insulin Market Revenue, By Application, 2015 – 2021 , (USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe Human Insulin Market Revenue, By Product, 2015 – 2021 (USD Billion)
      • 7.3.2. North America Human Insulin Market Revenue, By Application, 2015 – 2021 , (USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Human Insulin Market Revenue, By Product, 2015 – 2021 (USD Billion)
      • 7.4.2. North America Human Insulin Market Revenue, By Application, 2015 – 2021 , (USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America Human Insulin Market Revenue, By Product, 2015 – 2021 (USD Billion)
      • 7.5.2. North America Human Insulin Market Revenue, By Application, 2015 – 2021 , (USD Billion)
    • 7.6. Middle East And Africa
      • 7.6.1. Middle East And Africa Human Insulin Market Revenue, By Product, 2015 – 2021 (USD Billion)
      • 7.6.2. North America Human Insulin Market Revenue, By Application, 2015 – 2021 , (USD Billion)
  • Chapter 8. Company Profile
    • 8.1. Eli Lilly
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Type Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. GlaxoSmithCline
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Type Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Biocon
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Type Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. Sanofi Aventis
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Type Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. Julphar
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Type Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Developments
    • 8.6. Novo Nordisk
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Type Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Developments
    • 8.7. SemBioSys
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Type Portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Developments
    • 8.8. Wockhardt
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Type Portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Developments
  • Chapter 9. Patents
    • 9.1. U.S. (US Patents)
    • 9.2. Europe (EP documents)
    • 9.3. Japan (Abstracts of Japan)
    • 9.4. Global (WIPO (PCT))

List of Figures

1. Market Research Process
2. Market Research Methodology
3. Global Human Insulin Market Revenue, 2015 – 2021 (USD Billion)
4. Porter’s Five Forces Analysis
5. Human Insulin : Market Attractiveness Analysis, By Product Segment
6. Human Insulin : Market Attractiveness Analysis, By Application Segment
7. Human Insulin : Market Attractiveness Analysis, By Regional Segment
8. Company Market Share Analysis, 2015 And 2021
9. Global Human Insulin Market Revenue Share By Product, 2015 And 2021
10. Human Insulin Drug Market, 2015 – 2021, (USD Billion)
11. Human Insulin Market For Insulin Analogs and Biosimilars, 2015 – 2021, (USD Billion)
12. Human Insulin Market For Human Insulin Biologics, 2015 – 2021, (USD Billion)
13. Human Insulin Drug Delivery Devices Market, 2015 – 2021, (USD Billion)
14. Human Insulin Market For Pens, 2015 – 2021, (USD Billion)
15. Human Insulin Market For Pen Needles, 2015 – 2021, (USD Billion)
16. Human Insulin Market For Syringes, 2015 – 2021, (USD Billion)
17. Global Human Insulin Market Revenue Share By Application, 2015 And 2021
18. Human Insulin Market For Insulin Dependent Diabetes Mellitus (Type 1), 2015 – 2021, (USD Billion)
19. Human Insulin Market For Non-Insulin Dependent Diabetes Mellitus (Type 2), 2015 – 2021, (USD Billion)
20. Global Human Insulin Market Share, By Region, 2015 – 2021
21. North America Human Insulin Market, 2015 – 2021, (USD Billion)
22. Europe Human Insulin Market, 2015 – 2021, (USD Billion)
23. Asia Pacific Human Insulin Market, 2015 – 2021, (USD Billion)
24. Latin America Human Insulin Market, 2015-2021, (USD Billion)
25. Middle East & Africa Human Insulin Market, 2015 – 2021, (USD Billion)


List of Tables

1. Human Insulin Market: Market Snapshot
2. Drivers Of Global Human Insulin Market: Impact Analysis
3. Restraints Of Global Human Insulin Market: Impact Analysis
4. North America Human Insulin Market Revenue, By Product, 2015 – 2021(USD Billion)
5. North America Human Insulin Market Revenue, By Application, 2015 – 2021(USD Billion)
6. Europe Human Insulin Market Revenue, By Product, 2015 – 2021(USD Billion)
7. Europe Human Insulin Market Revenue, By Application, 2015 – 2021(USD Billion)
8. Asia Pacific Human Insulin Market Revenue, By Product 2015 – 2021(USD Billion)
9. Asia Pacific Human Insulin Market Revenue, By Application 2015 – 2021(USD Billion)
10. Latin America Human Insulin Market Revenue, By Product – 2021 (USD Billion)
11. Latin America Human Insulin Market Revenue, By Application – 2021 (USD Billion)
12. Middle East And Africa Human Insulin Market Revenue, By Product – 2021 (USD Billion)
13. Middle East And Africa Human Insulin Market Revenue, By Application – 2021 (USD Billion)

* Indicates required field.

Your Name*

Your Email*

Telephone Number*

Name of company*

Country Name*

How can we help you?

Prove You are Human*

captcha
Enter Capcha Image Properly



Share this Post

Related Posts

Checking...

Ouch! There was a server error.
Retry »

Sending message...

Enquiry Form

Fill in the form below and we will be in touch soon

Create Account



Log In Your Account